Can antivirals that target the host and not the virus improve outcomes for COVID-19 patients? Professor Eleanor Fish from the University of Toronto showed that treatment with interferon-alpha was beneficial in patients with SARS, and now shares early data on COVID-19.

The webinar is moderated by Juan-Carlos Zuniga-Pflücker, the Chair of the Department of Immunology at the University of Toronto.